CRISPR Crashes After Study Highlights Potential Cancer Risk From Gene-Editing | WHAT REALLY HAPPENED


CRISPR Crashes After Study Highlights Potential Cancer Risk From Gene-Editing

Editing cells’ genomes with CRISPR-Cas9 might increase the risk that the altered cells, intended to treat disease, will trigger cancer, two studies published on Monday warn — a potential game-changer for the companies developing CRISPR-based therapies.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA